Medios AG (FRA:ILM1)

Market Cap	311.17M
Revenue (ttm)	1.91B
Net Income (ttm)	14.94M
Shares Out	n/a
EPS (ttm)	0.59
PE Ratio	20.83
Forward PE	12.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45
Average Volume	383
Open	11.74
Previous Close	11.70
Day's Range	11.74 - 11.74
52-Week Range	10.32 - 18.52
Beta	n/a
RSI	49.17
Earnings Date	May 13, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, p...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2016
• Employees: 952
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.